Section Arrow
NVRO.NYSE
- NEVRO Corp
Quotes are at least 15-min delayed:2025/01/21 05:22 EST
Last
 4.57
+0.07 (+1.56%)
Day High 
4.66 
Prev. Close
4.5 
1-M High
4.565 
Volume 
388.86K 
Bid
4
Ask
4.78
Day Low
4.44 
Open
4.6 
1-M Low
3.165 
Market Cap 
168.62M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 3.81 
20-SMA 3.81 
50-SMA 4.26 
52-W High 19.47 
52-W Low 3.165 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
-1.87/-2.17
Enterprise Value
384.73M
Balance Sheet
Book Value Per Share
7.30
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
425.17M
Operating Revenue Per Share
11.28
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
QSIQuantum-Si2.24-0.3-11.81%-- 
SENSSenseonics Holdings0.8479-0.0271-3.10%-- 
BDMDBaird Medical Investment Holdings Ltd8.85+3.43+63.28%15.32PE
BMRABiomerica0.64-0.066-9.35%-- 
MDTMedtronic plc88.08+0.92+1.06%26.61PE
Quotes are at least 15-min delayed:2025/01/21 05:22 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Nevro Corp is a medical device company. Its key product is the HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. The company generates the majority of its revenue in the United States.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.